These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Antiarrhythmic therapy in patients with heart failure]. Faber TS; Zehender M Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993 [TBL] [Abstract][Full Text] [Related]
4. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies. Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243 [TBL] [Abstract][Full Text] [Related]
5. Arrhythmias and sudden death in heart failure. Stevenson WG; Sweeney MO Jpn Circ J; 1997 Sep; 61(9):727-40. PubMed ID: 9293402 [TBL] [Abstract][Full Text] [Related]
6. Management of hypertrophic cardiomyopathy in children. Seggewiss H; Rigopoulos A Paediatr Drugs; 2003; 5(10):663-72. PubMed ID: 14510624 [TBL] [Abstract][Full Text] [Related]
7. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators. Bollmann A; Husser D; Cannom DS Am J Cardiovasc Drugs; 2005; 5(6):371-8. PubMed ID: 16259525 [TBL] [Abstract][Full Text] [Related]
8. [Long-term outcome of pharmacological and nonpharmacological treatment for ventricular arrhythmias]. Ohnishi S; Kasanuki H J Cardiol; 2000 Mar; 35 Suppl 1():75-84. PubMed ID: 10834174 [TBL] [Abstract][Full Text] [Related]
9. Prevention and management of chronic heart failure with electrical therapy. Engelstein ED Am J Cardiol; 2003 May; 91(9A):62F-73F. PubMed ID: 12729852 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic decision tree for patients with sustained ventricular tachyarrhythmias or aborted cardiac arrest: a critical review of the Antiarrhythmics Versus Implantable Defibrillator trial and the Canadian Implantable Defibrillator Study. Farré J; Cabrera JA; Romero J; Rubio JM Am J Cardiol; 2000 Nov; 86(9A):44K-51K. PubMed ID: 11084100 [TBL] [Abstract][Full Text] [Related]
11. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study. Giorgberidze I; Saksena S; Krol RB; Munsif AN; Kolettis T; Mathew P; Varanasi S; Prakash A; Delfaut P; Lewis CB Am J Cardiol; 1997 Sep; 80(5B):3F-9F. PubMed ID: 9291444 [TBL] [Abstract][Full Text] [Related]
17. Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD? Wichter T; Paul TM; Eckardt L; Gerdes P; Kirchhof P; Böcker D; Breithardt G Herz; 2005 Mar; 30(2):91-101. PubMed ID: 15875097 [TBL] [Abstract][Full Text] [Related]
18. Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate. AbdelWahab A; Sapp J Curr Cardiol Rep; 2017 Sep; 19(11):105. PubMed ID: 28900864 [TBL] [Abstract][Full Text] [Related]
19. Controlling cardiac arrhythmias: an overview with a historical perspective. Singh BN Am J Cardiol; 1997 Oct; 80(8A):4G-15G. PubMed ID: 9354407 [TBL] [Abstract][Full Text] [Related]
20. [Management of arrhythmias in patients with heart failure]. Le Heuzey JY; Copie X; Piot O; Lavergne T; Henry P; Guize L Arch Mal Coeur Vaiss; 1998 Nov; 91(11):1371-6. PubMed ID: 9864606 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]